middle.news
EBR Systems Raises A$55.9m to Launch FDA-Approved Leadless WiSE CRT Device
1:52am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
EBR Systems Raises A$55.9m to Launch FDA-Approved Leadless WiSE CRT Device
1:52am on Monday 2nd of June, 2025 AEST
Key Points
A$55.9 million fully underwritten institutional placement
Additional A$6 million targeted via Security Purchase Plan
FDA approval received for WiSE CRT System in April 2025
Targeting US$3.6 billion initial addressable market in the US
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ebr Systems (ASX:EBR)
OPEN ARTICLE